Insights, Alerts

& Trends

Life Science Industry News

Insights, Alerts & Trends | Life Science IAT Life Science IAT SEPTEMBER 22

Life Science Industry News

Former Theranos employee testifies, drug pricing negotiation drama, and more.

Top of the News:

Biospace has some ideas on how to retain talent in the biotech sphere.


Democrats have announced their intention to vote against House Speaker Nancy Pelosi’s Medicare drug price negotiation plan that’s part of the House Energy & Commerce Committee’s input on a safety-net package, STAT News reports.


Patients and doctors who relied on telehealth services during the COVID-19 pandemic are advocating for its permanent adoption via regulatory efforts, The Philadelphia Inquirer writes.


Medical device companies are beginning to take on direct-to-consumer advertising in its marketing, MedTech Dive writes.


Doctor and medical groups are urging the Biden administration to extend Medicare telehealth flexibilities permanently, Fierce Healthcare writes.


A former Theranos lab worker testified about her concerns as to the company’s ability to perform blood tests, CNN writes.


Hospitals and medical centers can be one of the largest creators of carbon emissions, E&E News writes.

Professional Development:

Employees are leaving or planning on leaving in swarms, with reasons ranging from burnout to return-to-work conflicts. Inc. has more.